Skip to main content
. 2021 Aug 17;10(12):1080–1086. doi: 10.1093/jpids/piab073

Table 3.

Proportion of Derivation and Validation Cohorts Who Did Not Complete7-Vaccine Series by Age 19 Months by Risk Category

Risk Categorya Derivation Cohort (N = 6053) Validation Cohort (N = 3027)
n % n %
Low 1371/3543 38.7 664/1792 37.1
Medium 1027/1948 52.7 504/955 52.8
High 433/562 77.1 214/280 76.4

aLow (0-2 risk score), medium (3-4 risk score), and high (5-7 risk score).